13:09 · 6 November 2026

Quantum Computers are becoming a scarce commodity. IonQ has sold out its entire 2027 capacity

IonQ is beginning to turn quantum computing development into an increasingly substantial business. The company has raised its 2026 revenue guidance to $505–515 million, while all available capacity for its latest Superion 256 system in 2027 has already been contracted. This suggests customers are no longer simply exploring quantum technology. They are increasingly willing to pay for access to specific systems and reserve computing capacity well in advance.

IonQ previously expected revenue of $450–460 million. In the third quarter alone, the company generated $173.8 million in revenue, up 336% year over year. It was the sixth consecutive quarter in which IonQ reported record revenue. However, the impressive growth also reflects the acquisition of SkyWater, making it important to examine the two businesses separately.

IonQ Platform, which includes the company's quantum computing solutions, generated $90.3 million in revenue, representing 127% growth year over year. The remaining $83.5 million came from SkyWater Foundry Services, its semiconductor manufacturing and related services business. SkyWater significantly expands the scale of the overall group, but IonQ Platform's performance offers a clearer picture of progress in commercializing quantum technology.

Much of the attention is now focused on the Superion 256 system. The company announced that all available capacity for 2027 has already been sold out, with orders for 2028 also beginning to fill up. In practical terms, IonQ has increasingly limited capacity available for customers interested in its latest technology. Its next challenge is to turn this contracted demand into timely system deployments and additional revenue.

The company is also expanding its relationship with Nvidia. Superion 256 is expected to become the first quantum computer installed at Nvidia's Accelerated Quantum Research Center, where it will be connected to the company's supercomputing infrastructure. The two technologies are designed to complement each other: conventional processors and accelerators will handle most computing workloads, while quantum systems could support them in selected, more demanding tasks.

Beyond quantum computers, IonQ is developing quantum networking, sensing and cybersecurity solutions. It is also pursuing government contracts. The company has advanced to the next stage of the Quantum Benchmarking Initiative run by the US Defense Advanced Research Projects Agency (DARPA), a program with a potential value of up to $300 million.

Rising revenue does not mean IonQ is close to profitability. Adjusted EBITDA loss reached $133.6 million in the third quarter. The reported net income of $564 million was largely driven by a non-cash gain from the revaluation of warrants rather than an improvement in underlying operating performance.

The company does, however, have substantial resources to fund further expansion. Following a $2 billion share offering in October, IonQ had approximately $3.7 billion in cash, cash equivalents and investments. This gives it considerable flexibility to finance research and increase production capacity, although the share offering also diluted existing shareholders.

IonQ is still operating in a young market where quantum computing applications are only beginning to move beyond research and experimentation. Nevertheless, the company is already generating growing revenue from its own platform, securing customers for future systems and selling out Superion 256 capacity for 2027. The next test will be delivering on those orders while improving profitability. Demand is becoming less of an unknown for IonQ. The company now needs to prove that it can turn that demand into a profitable business.

Source: XTB Reserach

6 November 2026, 23:12

Daily summary: Wall Street rebounds after the sell-off 🔼 US dollar strengthens on solid NFP data, oil prices fall

6 November 2026, 23:00

Vistra shares surge nearly 10% after earnings, driven by strong AI power demand

6 November 2026, 19:27

US Open: Nasdaq rebounds after the largest decline since 19-month 🔼 Lam Research surges 12%

6 November 2026, 15:53

Airbnb surges 12% driven by revenue dynamic at 3-year high

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.